Copyright © 2015 Jinhee Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Contact hours:
- Pharmacotherapy hours: 3
- Expiration date: April 1, 2020
- Course price: $29
Screening, brief interventions, and treatment of alcohol use disorders and pharmacotherapies for substance-related and addictive disorders. Discussion of opioid use disorder, treatment, and overdose prevention as well as relapse prevention. Covers pharmacotherapies in opioid dependence to HIV.
ATrain Education, Inc. is an approved provider by the American Occupational Therapy Association. The following course information applies to occupational therapy professionals:
- Target Audience: Occupational Therapists, OTAs
- Instructional Level: Advanced
Criteria for Successful Completion
80% or higher on the post test, a completed evaluation form, and payment where required. No partial credit will be awarded.
Conflict of Interest/Commercial Support
Objectives: When you finish this course you will be able to:
- Explain how alcohol use disorders and opioid dependence can be initially addressed effectively by primary care providers.
- Give 4 examples of brief interventions that can be made at the primary care level.
- Name 6 medications that can be used in the treatment of substance use disorders.
- Name 3 medications that are used in the treatment of opioid use disorders and distinguish among them.
- Discuss the unique position of primary healthcare providers in addressing the risk for overdose or relapse to opioid use.
- Name 3 interventions that combine to offer the best course for relapse prevention.
- Explain the potential role of buprenorphine in integrating medication assisted treatment for opioid dependence with treatment for HIV and discuss the barriers to this integration.
- Describe prescription drug monitoring programs (PDMPs) and explain the federal programs that support their use.